Read Research Alzheimer's More' title='Share this by email.' class='social email'>           

Exploring APOE genotype effects on AD risk and β-amyloid burden in individuals with subjective cognitive decline: The FACEHBI study baseline results

Subjective cognitive decline (SCD) has been proposed as a potential preclinical stage of Alzheimer’s disease (AD). Nevertheless, the genetic and biomarker profiles of SCD individuals remain mostly unexplored. Read & Research Alzheimer’s More

Leave a Reply